1 |
GRIFFITHS C E M, ARMSTRONG A W, GUDJONSSON J E, et al.. Psoriasis[J]. Lancet, 2021, 397(10281): 1301-1315.
|
2 |
KAMIYA K, KISHIMOTO M, SUGAI J, et al.. Risk factors for the development of psoriasis[J/OL]. Int. J. Mol. Sci., 2019, 20(18): 4347[2023-09-10]. .
|
3 |
HBOEHNCKE W, SCHÖN M P. Psoriasis[J]. Lancet, 2015, 386(9997): 983-994.
|
4 |
CAPON F. The genetic basis of psoriasis[J]. Int. J. Mol. Sci., 2017, 18(12): 563-567.
|
5 |
VIČIĆ M, KAŠTELAN M, BRAJAC I, et al.. Current concepts of psoriasis immunopathogenesis[J/OL]. Int. J. Mol. Sci., 2021, 22(21): 11574[2023-09-10]. .
|
6 |
RGEORGESCU S, TAMPA M, CARUNTU C, et al.. Advances in understanding the immunological pathways in psoriasis[J/OL]. Int. J. Mol. Sci., 2019, 20(3): 739[2023-09-10]. .
|
7 |
CDOBRICĂ E, ACOZMA M, AGĂMAN M, et al.. The involvement of oxidative stress in psoriasis: a systematic review[J/OL]. Antioxidants, 2022, 11(2): 282[2023-09-10]. .
|
8 |
PLEŃKOWSKA J, GABIG-CIMIŃSKA M, MOZOLEWSKI P. Oxidative stress as an important contributor to the pathogenesis of psoriasis[J/OL]. Int. J. Mol. Sci., 2020, 21(17): 6206[2023-09-10]. .
|
9 |
KADAM D P, SURYAKAR A N, ANKUSH R D, et al.. Role of oxidative stress in various stages of psoriasis[J]. Indian J. Clin. Biochem., 2010, 25(4): 388-392.
|
10 |
LISSE T S, KING B L, RIEGER S. Comparative transcriptomic profiling of hydrogen peroxide signaling networks in zebrafish and human keratinocytes: implications toward conservation, migration and wound healing[J/OL]. Sci. Rep., 2016, 6: 20328[2023-09-10]. .
|
11 |
BARYGINA V, BECATTI M, PRIGNANO F, et al.. Fibroblasts to keratinocytes redox signaling: the possible role of ROS in psoriatic plaque formation[J/OL]. Antioxidants, 2019, 8(11): 566[2023-09-10]. .
|
12 |
SHAH A A, SINHA A A. Oxidative stress and autoimmune skin disease[J]. Eur. J. Dermatol., 2013, 23(1): 5-13.
|
13 |
PELUSO I, CAVALIERE A, PALMERY M. Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis[J/OL]. J. Biomed. Sci., 2016, 23(1): 52[2023-09-10]. .
|
14 |
MEDOVIC M V, JAKOVLJEVIC V L, ZIVKOVIC V I, et al.. Psoriasis between autoimmunity and oxidative stress: changes induced by different therapeutic approaches[J/OL]. Oxid. Med. Cell. Longev., 2022, 2022: 2249834[2023-09-10]. .
|
15 |
ISHIBASHI T, ICHIKAWA M, SATO B, et al.. Improvement of psoriasis-associated arthritis and skin lesions by treatment with molecular hydrogen: a report of three cases[J]. Mol. Med. Rep., 2015, 12(2): 2757-2764.
|
16 |
ZHU Q, WU Y, LI Y, et al.. Positive effects of hydrogen-water bathing in patients of psoriasis and parapsoriasis en plaques[J/OL]. Sci. Rep., 2018, 8(1): 8051[2023-09-10]. .
|
17 |
ZHOU P, LIN B, WANG P, et al.. The healing effect of hydrogen-rich water on acute radiation-induced skin injury in rats[J]. J. Radiat. Res., 2019, 60(1): 17-22.
|
18 |
ASADA R, SAITOH Y, MIWA N. Effects of hydrogen-rich water bath on visceral fat and skin blotch, with boiling-resistant hydrogen bubbles[J]. Med. Gas Res., 2019, 9(2): 68-73.
|
19 |
BAJGAI J, LEE K J, RAHMAN M H, et al.. Role of molecular hydrogen in skin diseases and its impact in beauty[J]. Curr. Pharm. Des., 2021, 27(5): 737-746.
|
20 |
OSTOJIC S M. Molecular hydrogen: an inert gas turns clinically effective[J]. Ann. Med., 2015, 47(4): 301-304.
|
21 |
冯艳, 王傲, 李思彤, 等. 银屑病小鼠模型研究进展[J]. 中国中西医结合皮肤性病学杂志, 2019, 18(4): 380-383.
|
22 |
彭玲玲, 延祝, 夏育民. 银屑病的动物模型与细胞模型研究进展[J]. 皮肤性病诊疗学杂志, 2020, 27(3): 204-206.
|
23 |
SINGH R, KOPPU S, PERCHE P O, et al.. The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications[J/OL]. Int. J. Mol. Sci., 2021, 22(23): 12793[2023-09-10]. .
|
24 |
SRIVASTAVA A, LUO L, LOHCHAROENKAL W, et al.. Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis[J]. J. Allergy Clin. Immunol., 2021, 147(6): 2225-2235.
|
25 |
ZHANG Z, TANG S, JIANG Y, et al.. Oxidative stress induces meiotic defects of oocytes in a mouse psoriasis model[J/OL]. Cell Death Dis., 2022, 13(5): 474[2023-09-10]. .
|
26 |
LAI R, XIAN D, XIONG X, et al.. Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells[J]. Redox Rep., 2018, 23(1): 130-135.
|
27 |
WU C S, LIN C C, CHEN Y Y, et al.. Mechanisms and effects of isorhamnetin on imiquimod-induced psoriasiform dermatitis in mice[J/OL]. Life, 2022, 12(12): 2107[2023-09-10]. .
|
28 |
GAO J, CHEN F, FANG H, et al.. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice[J/OL]. Biol. Res., 2020, 53(1): 48[2023-09-10]. .
|
29 |
DU P, ZHANG W, CUI H, et al.. Sulforaphane ameliorates the severity of psoriasis and SLE by modulating effector cells and reducing oxidative stress[J/OL]. Front. Pharmacol., 2022, 13: 805508[2023-09-10]. .
|
30 |
SRIVASTAVA A, LUO L, LOHCHAROENKAL W, et al.. Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis[J]. J. Allergy Clin. Immunol., 2021, 147(6): 2225-2235.
|
31 |
HU P, WANG M, GAO H, et al.. The role of helper T cells in psoriasis[J/OL]. Front. Immunol., 2021, 12: 788940[2023-09-10]. .
|
32 |
BAEK J O, BYAMBA D, WU W H, et al.. Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress[J]. Arch. Dermatol. Res., 2012, 304(9): 699-706.
|
33 |
YOUNG C N, KOEPKE J I, TERLECKY L J, et al.. Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease[J]. J. Invest. Dermatol., 2008, 128(11): 2606-2614.
|
34 |
ZHANG X, YU P, HONG N, et al.. Effect and mechanism of hydrogen-rich bath on mice with imiquimod-induced psoriasis[J]. Exp. Dermatol., 2023, 32(10): 1674-1681.
|
35 |
陈军, 秦树存, 何磊. 富氢盐水对咪喹莫特诱导小鼠银屑病的抑制作用[J]. 生物技术进展, 2022, 12(4): 503-509.
|
36 |
陶鸽如, 秦树存. 氢生物医学效应在疏解自由基氧化应激的分子机制[J]. 生物技术进展, 2022, 12(4): 490-496.
|
37 |
SIES H. Oxidative stress: a concept in redox biology and medicine[J]. Redox Biol., 2015, 4: 180-183.
|
38 |
GAŠPERLIN M, GOSENCA M. Main approaches for delivering antioxidant vitamins through the skin to prevent skin ageing[J]. Expert Opin. Drug Deliv., 2011, 8(7): 905-919.
|
39 |
YILDIRIM M, INALOZ H S, BAYSAL V, et al.. The role of oxidants and antioxidants in psoriasis[J]. J. Eur. Acad. Dermatol. Venereol., 2003, 17(1): 34-36.
|
40 |
SIKAR A A, ÖZDOĞAN H K, BAYRAMGÜRLER D, et al.. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients[J]. J. Eur. Acad. Dermatol. Venereol., 2012, 26(7): 833-837.
|